Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Cited In for PubMed (Select 18056553)

1.

Use of the Progressive Aphasia Severity Scale (PASS) in monitoring speech and language status in PPA.

Sapolsky D, Domoto-Reilly K, Dickerson BC.

Aphasiology. 2014 Jan 1;28(8-9):993-1003.

2.

SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment.

Zoller AS, Gaal IM, Royer CA, Locascio JJ, Amariglio RE, Blacker D, Okereke OI, Johnson KA, Sperling RA, Rentz DM, Marshall GA.

Curr Alzheimer Res. 2014;11(8):785-91.

3.

Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease.

Pereira ML, Camargo Mv, Aprahamian I, Forlenza OV.

Neuropsychiatr Dis Treat. 2014 Jul 9;10:1273-85. doi: 10.2147/NDT.S55371. eCollection 2014. Review.

4.

The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study.

Hessen E, Reinvang I, Eliassen CF, Nordlund A, Gjerstad L, Fladby T, Wallin A.

Dement Geriatr Cogn Dis Extra. 2014 Apr 9;4(1):76-85. doi: 10.1159/000360282. eCollection 2014 Jan.

5.

Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up.

Li S, Okonkwo O, Albert M, Wang MC.

Am J Alzheimers Dis (Columbia). 2013;2(1):12-28.

6.

The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's disease.

Vasconcelos Lde G, Jackowski AP, Oliveira MO, Flor YM, Souza AA, Bueno OF, Brucki SM.

Clinics (Sao Paulo). 2014 Jan;69(1):28-37. doi: 10.6061/clinics/2014(01)05.

7.

Decreased cognitive function in extended family members from the single late-onset-Alzheimer's-disease pedigree.

Zeng Y, Chang W, Shu C, Ma L, Huang Y, Wang R, Zhang J, Zhu C, McClintock SM.

J Int Neuropsychol Soc. 2013 Aug;19(7):809-19. doi: 10.1017/S1355617713000581. Epub 2013 Jun 7.

8.

Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics?

Weissberger GH, Salmon DP, Bondi MW, Gollan TH.

Neuropsychology. 2013 May;27(3):343-55. doi: 10.1037/a0032399.

9.

Recognition of famous names predicts cognitive decline in healthy elders.

Seidenberg M, Kay CD, Woodard JL, Nielson KA, Smith JC, Kandah C, Guidotti Breting LM, Novitski J, Lancaster M, Matthews M, Hantke N, Butts A, Rao SM.

Neuropsychology. 2013 May;27(3):333-42. doi: 10.1037/a0032226.

10.

Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes.

Fung WL, Naylor MG, Bennett DA, Lange C, Blacker D.

Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):770-8. doi: 10.1002/ajmg.b.32151. Epub 2013 May 6.

11.

Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints.

Macklin EA, Blacker D, Hyman BT, Betensky RA.

J Alzheimers Dis. 2013;36(3):475-86. doi: 10.3233/JAD-122212.

12.

The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG.

Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95. doi: 10.1016/j.jagp.2013.01.006. Epub 2013 Feb 6.

13.

Alzheimer disease alters the relationship of cardiorespiratory fitness with brain activity during the stroop task.

Vidoni ED, Gayed MR, Honea RA, Savage CR, Hobbs D, Burns JM.

Phys Ther. 2013 Jul;93(7):993-1002. doi: 10.2522/ptj.20120465. Epub 2013 Apr 4.

14.

P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia.

Parra MA, Ascencio LL, Urquina HF, Manes F, Ibáñez AM.

Front Neurol. 2012 Dec 5;3:172. doi: 10.3389/fneur.2012.00172. eCollection 2012.

15.

Four-year outcome of mild cognitive impairment: the contribution of executive dysfunction.

Aretouli E, Tsilidis KK, Brandt J.

Neuropsychology. 2013 Jan;27(1):95-106. doi: 10.1037/a0030481. Epub 2012 Oct 29.

16.

Subjective cognitive complaints and amyloid burden in cognitively normal older individuals.

Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, Maye JE, Gidicsin C, Pepin LC, Sperling RA, Johnson KA, Rentz DM.

Neuropsychologia. 2012 Oct;50(12):2880-6. doi: 10.1016/j.neuropsychologia.2012.08.011. Epub 2012 Aug 23.

17.

An investigation of PreMCI: subtypes and longitudinal outcomes.

Loewenstein DA, Greig MT, Schinka JA, Barker W, Shen Q, Potter E, Raj A, Brooks L, Varon D, Schoenberg M, Banko J, Potter H, Duara R.

Alzheimers Dement. 2012 May;8(3):172-9. doi: 10.1016/j.jalz.2011.03.002.

18.

Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study.

Sosa AL, Albanese E, Stephan BC, Dewey M, Acosta D, Ferri CP, Guerra M, Huang Y, Jacob KS, Jiménez-Velázquez IZ, Rodriguez JJ, Salas A, Williams J, Acosta I, González-Viruet M, Hernandez MA, Shuran L, Prince MJ, Stewart R.

PLoS Med. 2012 Feb;9(2):e1001170. doi: 10.1371/journal.pmed.1001170. Epub 2012 Feb 7.

19.

Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Morris JC.

Arch Neurol. 2012 Jun;69(6):700-8. doi: 10.1001/archneurol.2011.3152.

20.

MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults.

Dickerson BC, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 Jan 10;78(2):84-90. doi: 10.1212/WNL.0b013e31823efc6c. Epub 2011 Dec 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk